Recruiting
Phase 2
Phase 3

Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Sponsor:

NRG Oncology

Code:

NCT05050162

Conditions

Advanced Head and Neck Squamous Cell Carcinoma

Advanced Hypopharyngeal Squamous Cell Carcinoma

Advanced Laryngeal Squamous Cell Carcinoma

Advanced Oropharyngeal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Unknown Primary

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cisplatin

Cisplatin

Quality-of-Life Assessment

Questionnaire Administration

Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information